OBIO Hosts Industry Roundtable with BIO Digital Delegation Companies
Last week, OBIO organized and hosted a virtual roundtable discussion with health science companies that participated in the Ontario delegation to the BIO Digital 2020 conference. The interactive discussion allowed participants to share their experiences about adjusting to building companies virtually.
Cyclica Raises CAD$23M In a Series B Financing
Cyclica has announced the close of a CAD$23M Series B round of financing.
New Recovery Activation Program to Support Digital Transformation of Companies
The Toronto Region Board of Trade’s has launched Recovery Activation Program (RAP), an immersive online workshop program to provide businesses with guidance, mentorship and practical advice about process modernization and end-to-end digital transformation.
Empirica Therapeutics Acquired by Century Therapeutics
Century Therapeutics has announced that it has acquired Empirica Therapeutics, allowing the company to develop its iPSC derived allogeneic cell therapies against glioblastoma (GBM).
Health Canada Issues Notice of Compliance for Bausch Health's DUOBRII™
Bausch Health Companies has announced that Health Canada has approved the use of DUOBRII™ lotion, a topical prescription medicine used to improve the signs and symptoms of plaque psoriasis in adult patients with moderate to severe plaque psoriasis.
UPDATED: Fusion Pharmaceuticals Set for IPO
Fusion Pharmaceuticals has announced that it expects to sell 8.35 million shares ranging from $14 to $16 in its initial public offering.
Health Research Foundation Launches Research Chair in Pandemic Preparedness
The Health Research Foundation (HRF) of Innovative Medicines Canada (IMC) have announced details of the Health Research Foundation of Innovative Medicines Canada Chair in Pandemic Preparedness Research.
OBIO’s Health to Business Bridge Program (H2BB) is Preparing the Future Leaders of Ontario’s Health Science Industry
OBIO’s Health to Business Bridge™ Program (H2BB) prepares new hires for careers in Ontario’s health science industry, helping companies build for the future in an innovative sector poised for growth.
MyndTec Partners with Maness Veteran Medical to Distribute MyndMove™ to US Veterans and Active Military
MyndTec has partnered with Maness Veteran Medical to distribute its MyndMove™ Device to the US Department of Defense and The Department of Veterans Affairs.
Epineuron Technologies Closes Financing for its Breakthrough Nerve Regeneration Device
Epineuron Technologies, Inc., announces the completion of a financing round to support production development and clinical validation for its neuroregenerative technology - designated a breakthrough device by the FDA.
Spiderwort closes $2.5M USD Series Seed Financing
Spiderwort Inc. has announced the closing of their $2.5 million USD Series Seed round financing.
VBI Vaccines Secures $50M Debt Financing from K2 HealthVentures
VBI Vaccines Inc. has announced that it has entered into a debt financing facility for up to $50 million with K2 HealthVentures.
Flosonics Medical Among Winners of the Vale COVID-19 Challenge
Flosonics Medical is one of the winners of the Vale COVID-19 challenge to help move solutions to market.
OBIO Announces Early Adopter Health Network Call for Applications to Address COVID-19
This is a call to action for companies developing health technologies including COVID-19 management and treatment technologies to be evaluated for commercial readiness within its Early Adopter Health Network
OBIO H2BB Next Term Begins May 27
Limited Spots Available - Contact Us Today! Make OBIO H2BB part of the onboarding you provide new hires and increase employee productivity, development and retention, as well having a competitive edge as you seek top talent.
Lumira Ventures Launches the Double Bottom Line Challenge
Lumira Ventures has launched the Double Bottom Line Challenge to provide funding to community organizations which are supporting groups that have been significantly affected by COVID-19.
Virtual Velocity Fund Pitch Competition
The Velocity Fund Pitch Competition is open for applications. The Fund will invest $50,000 to $100,000 in each of the top four promising, early-stage companies.
Dr. Michael Rudnicki Named a Fellow of The Royal Society
Dr. Michael Rudnicki, Senior Scientist and Program Director, Ottawa Health Research Institute, has been named a Fellow of The Royal Society.
Perimeter Medical Imaging Receives $10.4 Million Grant
Microbix Biosystems Attains Health Canada Establishment Licensing
Microbix Biosystems has attained medical devices establishment licensing from Health Canada, allowing the immediate use of its quality assessment products by clinical laboratories across the country,